Aeglea BioTherapeutics, Inc. (21) | Uncategorized (4)
- Offer Letter, dated June 14, 2021 issued by the Registrant to Mr. Jonathan Alspaugh (Filed With SEC on March 8, 2022)
- Description of the Registrant's securities (Filed With SEC on March 18, 2021)
- Offer letter, dated March 13, 2020 issued by the Registrant to Dr. Leslie Sloan (Filed With SEC on May 7, 2020)
- Description of the Registrant's securities (Filed With SEC on February 24, 2020)
